Endogenous and exogenous sex steroid hormones in asthma and allergy in females: A systematic review and meta-analysis - 05/04/18
Doi : 10.1016/j.jaci.2017.11.034
Nicola McCleary, PhD a, b, ∗ 
, Bright I. Nwaru, PhD a, c, d, ∗, Ulugbek B. Nurmatov, PhD a, e, Hilary Critchley, MD f, Aziz Sheikh, MD a
, Bright I. Nwaru, PhD a, c, d, ∗, Ulugbek B. Nurmatov, PhD a, e, Hilary Critchley, MD f, Aziz Sheikh, MD a a Asthma UK Centre for Applied Research, Centre for Medical Informatics, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom
b Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada
c Krefting Research Centre, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
d Wallenberg Centre for Molecular and Translational Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden
e Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, United Kingdom
f Medical Research Council Centre for Reproductive Health, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom
| This work was supported by the Chief Scientist Office, Scotland (grant no. CZH/4/1083). A.S. is also supported by the Asthma UK Centre for Applied Research and the Farr Institute. The funder had no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the article for publication. B.I.N. acknowledges the support of Knut and Alice Wallenberg Foundation and the Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg. |
|
| Disclosure of potential conflict of interest: N. McCleary’s institution, B. I. Nwaru’s institution, and A. Sheikh’s institution have received funds from the Chief Scientist Office of Scotland (grant no. CZH/4/1083). U. B. Nurmatov’s institution has received funds from the Chief Scientist Office of Scotland (grant no. CZH/4/1083). He has also received travel funds from the Chief Scientist Office of Scotland. H. Critchley’s institution has received funds from the Chief Scientist Office of Scotland (grant no. CZH/4/1083). She also receives funds for board membership and consultancy from Bayer AG, PreLemSA, Gedeon Richter, Vifor Pharma UK Ltd, AbbVie Inc, and Myovant Sciences GmbH and has grants pending from the Medical Research Council and Bayer AG. |
© 2018
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 141 - N° 4
P. 1510 - avril 2018 Retour au numéro
Article précédent
- RELA haploinsufficiency in CD4 lymphoproliferative disease with autoimmune cytopenias
- William A. Comrie, Aiman J. Faruqi, Susan Price, Yu Zhang, V. Koneti Rao, Helen C. Su, Michael J. Lenardo
- A Canadian genome-wide association study and meta-analysis confirm HLA as a risk factor for peanut allergy independent of asthma
- Yuka Asai, Aida Eslami, C. Dorien van Ginkel, Loubna Akhabir, Ming Wan, David Yin, George Ellis, Moshe Ben-Shoshan, Ingo Marenholz, David Martino, Manuel A. Ferreira, Katrina Allen, Bruce Mazer, Hans de Groot, Nicolette W. de Jong, Roy Gerth van Wijk, Anthony E.J. Dubois, Sarah Grosche, Sarah Ashley, Franz Rüschendorf, Birgit Kalb, Kirsten Beyer, Markus M. Nöthen, Young-Ae Lee, Rick Chin, Stephen Cheuk, Joshua Hoffman, Eric Jorgensen, John S. Witte, Ronald B. Melles, Xiumei Hong, Xiaobin Wang, Jennie Hui, Arthur W. (Bill) Musk, Michael Hunter, Alan L. James, Gerard H. Koppelman, Andrew J. Sandford, Ann E. Clarke, Denise Daley
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?